Plexium, Inc.

R&D leaders from Amgen, Inc. , Johnson & Johnson and Takeda Pharmaceutical Co. Ltd. deliberated, at a recent summit, the potential of big data to uncover biological insights and complex issues ar

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Gets 5T4-Targeted NK Cell Therap

Targeted protein degradation, or TPD, has been steadily gaining attention in recent years as a highly promising new drug development strategy that has already attracted significant investment and big

Targeted protein degradation, or TPD, has been steadily gaining attention in recent years as a highly promising new drug development strategy that has already attracted significant investment and big